Skip to main content
Clinical Trials/RBR-22t943
RBR-22t943Recruiting未知

Impact on mortality and cost-effectiveness of a protocol for diagnosis and treatment of tuberculosis in People Living with HIV

Conselho Nacional d eDeswenvolvimento Cientifico e Tecnologico0 sitesStarted: July 16, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Intervention

Eligibility Criteria

Ages
18Y to — (—)

Inclusion Criteria

  • HIV positive patients who were diagnosed with HIV; aged 18 years or over; and attended in Correia Picanco Hospital before initiating ART.

Exclusion Criteria

  • Being treated for TB; We have been treated for tuberculosis in the last three months; be receiving antiretroviral therapy over a month.

Investigators

Sponsor
Conselho Nacional d eDeswenvolvimento Cientifico e Tecnologico

Similar Trials

Active, not recruiting
Phase 1
IMPACT ON THE CLINICAL OUTCOMES AND COST-EFFECTIVENESS OF THE ANTIMICROBIAL THERAPEUTIC MONITORING PROGRAM IN CRITICAL PATIENTS- Respiratory infections- Urogenital infections - Abdominal infectionsMedDRA version: 20.1Level: LLTClassification code 10056570Term: Intra-abdominal infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10038700Term: Respiratory infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: PTClassification code 10065583Term: Urogenital infection bacterialSystem Organ Class: 10021881 - Infections and infestations
EUCTR2019-004947-65-ESSantiago Grau Cerrato230
Completed
Not Applicable
The clinical, organisational and cost consequences of computer-assisted telephone advice to category C 999 ambulance service callers: results of a controlled trialComputer-assisted telephone advice for emergency services
ISRCTN30837187Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Active, not recruiting
Phase 1
What is the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin?pper limb spasticity following stroke
EUCTR2004-002427-40-GBewcastle Upon Tyne Hospitals NHS Foundation Trust332
Completed
Not Applicable
What is the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin?pper limb spasticity due to strokeCirculatory SystemStroke
ISRCTN78533119The Newcastle Upon Tyne Hospitals NHS Foundation Trust (UK)390
Not yet recruiting
Not Applicable
BeNEFIT: Bringing eHealth Nutrition Education to populations For Improved depression TreatmentMental Health - DepressionPublic Health - Health promotion/educationMajor Depressive Disorder
ACTRN12622000693729Deakin University672